| Literature DB >> 28003290 |
Marinella Gugliotta1, Bruno R da Costa2, Essam Dabis3, Robert Theiler3,4, Peter Jüni5,6, Stephan Reichenbach7,8, Hans Landolt1, Paul Hasler3.
Abstract
OBJECTIVES: Evidence comparing the effectiveness of surgical and conservative treatment of symptomatic lumbar disc herniation is controversial. We sought to compare short-term and long-term effectiveness of surgical and conservative treatment in sciatica symptom severity and quality of life in patients with lumbar disc herniation in a routine clinical setting.Entities:
Keywords: SURGERY; conservative; hernia; prolapse; sciatica
Mesh:
Year: 2016 PMID: 28003290 PMCID: PMC5223716 DOI: 10.1136/bmjopen-2016-012938
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Flow of patients through the different stages of the trial.
Patient characteristics at baseline
| Surgical (n=297) | Conservative (n=73) | p Value | Adjusted p Value* | |
|---|---|---|---|---|
| Age (years, mean±SD) | 50.4±13.5 | 49.8±12.7 | 0.66 | 0.69 |
| BMI (kg/m2, mean±SD) | 26.7±4.5 | 27.3±4.4 | 0.27 | 0.79 |
| Male gender, n (%) | 168 (56.6) | 43 (58.9) | 0.72 | 0.74 |
| Social class, n (%) | 0.065 | 0.96 | ||
| Blue collar | 132 (44.4) | 38 (52.1) | ||
| White collar | 74 (24.9) | 12 (16.4) | ||
| Not working | 33 (11.1) | 14 (19.2) | ||
| Retired | 58 (19.5) | 9 (12.3) | ||
| Country of origin, n (%) | ≤0.001 | 0.94 | ||
| Switzerland | 255 (85.9) | 46 (63.0) | ||
| Foreign | 42 (14.1) | 27 (37.0) | ||
| Social, n (%) | 0.84 | 0.92 | ||
| Family | 247 (83.2) | 60 (82.2) | ||
| Single | 50 (16.8) | 13 (17.8) | ||
| NASS, mean±SD | ||||
| Pain† | 7.8±2.2 | 7.7±2.7 | 0.64 | 0.88 |
| Neurogenic symptoms‡ | 18.8±6.7 | 17.3±8.3 | 0.098 | 0.84 |
| Function§ | 24.7±8.4 | 25.8±9.3 | 0.32 | 0.72 |
| SF-36, mean±SD | ||||
| Physical¶ | 26.5±7.0 | 27.3±6.8 | 0.39 | 1.00 |
| Mental¶ | 48.7±12.5 | 46.8±14.5 | 0.26 | 0.93 |
*p Value after adjustment with inverse probability weighting.
Possible NASS subscale scores range from †0 to 10, ‡0 to 30 and §0 to 45; lower scores indicate lower severity of symptoms.
¶Possible score range for both SF-36 subscales is 0 to 100; higher scores indicate lower severity of symptoms.
BMI, body mass index; NASS, North American Spine Society lumbar spine outcome assessment instrument; SF-36, 36-Item Short-Form Health Survey.
Primary and secondary outcomes in all follow-up assessments
| Surgical (n=297) | Control (n=73) | Difference | |
|---|---|---|---|
| NASS back pain*, mean (95% CI) | |||
| 6 weeks | 4.4 (4.0 to 4.7) | 5.3 (4.5 to 6.2) | −1.0 (−1.9 to −0.1) |
| 12 weeks | 4.8 (4.4 to 5.1) | 5.1 (4.2 to 6.0) | −0.3 (−1.3 to 0.6) |
| 1 year | 4.5 (4.1 to 4.9) | 4.7 (3.8 to 5.6) | −0.2 (−1.2 to 0.8) |
| 2 years | 4.4 (4.0 to 4.8) | 4.5 (3.5 to 5.5) | −0.1 (−1.2 to 1.0) |
| Response to treatment, % (95% CI) | |||
| 6 weeks | 48 (36 to 60) | 17 (8 to 25) | 34 (16 to 47) |
| 12 weeks | 35 (24 to 46) | 24 (13 to 35) | 9 (−6 to 27) |
| 1 year | 42 (30 to 55) | 35 (15 to 54) | 3 (−15 to 30) |
| 2 years | 44 (30 to 58) | 49 (21 to 77) | −17 (−36 to 26) |
| NASS neurogenic†, mean (95% CI) | |||
| 6 weeks | 16.5 (14.8 to 18.2) | 20.0 (16.2 to 23.9) | −3.5 (−7.7 to 0.7) |
| 12 weeks | 14.7 (13.0 to 16.4) | 18.2 (14.3 to 22.0) | −3.5 (−7.7 to 0.7) |
| 1 year | 14.0 (12.2 to 15.7) | 17.1 (12.7 to 21.5) | −3.1 (−7.9 to 1.6) |
| 2 years | 14.1 (12.2 to 16.0) | 15.4 (10.6 to 20.2) | −1.3 (−6.3 to 3.7) |
| NASS function‡, mean (95% CI) | |||
| 6 weeks | 17.9 (16.5 to 19.4) | 17.3 (14.1 to 20.5) | 0.7 (−2.8 to 4.2) |
| 12 weeks | 13.7 (12.4 to 14.9) | 17.0 (13.6 to 20.3) | −3.3 (−6.9 to 0.3) |
| 1 year | 11.5 (10.2 to 12.9) | 15.3 (11.9 to 18.6) | −3.7 (−7.4 to −0.1) |
| 2 years | 12.5 (10.9 to 14.0) | 13.6 (9.8 to 17.4) | −1.1 (−5.2 to 2.9) |
| SF-36 physical function§, mean (95% CI) | |||
| 6 weeks | 33.2 (31.8 to 34.6) | 36.3 (33.4 to 39.1) | −3.1 (−6.4 to 0.1) |
| 12 weeks | 38.0 (36.7 to 39.3) | 37.8 (34.4 to 41.2) | 0.2 (−3.5 to 3.8) |
| 1 year | 41.0 (39.4 to 42.5) | 40.3 (36.7 to 43.8) | 0.7 (−3.2 to 4.6) |
| 2 years | 42.1 (40.3 to 44.0) | 42.8 (39.1 to 46.4) | −0.6 (−4.7 to 3.5) |
| SF-36 mental function§, mean (95% CI) | |||
| 6 weeks | 47.9 (45.8 to 49.9) | 48.2 (44.3 to 52.2) | −0.4 (−4.9 to 4.1) |
| 12 weeks | 49.3 (47.6 to 51.0) | 47.5 (43.6 to 51.3) | 1.8 (−2.3 to 6.0) |
| 1 year | 50.3 (48.7 to 51.9) | 47.9 (43.9 to 51.8) | 2.4 (−1.9 to 6.7) |
| 2 years | 49.1 (47.0 to 51.1) | 47.7 (43.5 to 52.0) | 1.3 (−3.5 to 6.1) |
Possible NASS subscale scores range from *0 to 10, †0 to 30 and ‡0 to 45; lower scores indicate lower severity of symptoms.
§Possible score range for both SF-36 subscales is 0 to 100; higher scores indicate lower severity of symptoms.
NASS, North American Spine Society lumbar spine outcome assessment instrument; SF-36, 36-Item Short-Form Health Survey.
Figure 2Mean scores with 95% CI of the subscales of the North American Spine Society (NASS) questionnaire at baseline and subsequent follow-up assessments.
Figure 3Mean scores with 95% CI of the subscales of the 36-Item Short-Form Health Survey (SF-36) at baseline and subsequent follow-up assessments.